申请人:Hu Jingdan
公开号:US20110028520A1
公开(公告)日:2011-02-03
CB-1 receptor inverse agonist compounds of Formula and pharmaceutical compositions for the treatment of obesity or cognitive impairment associated with schizophrenia.
公式为CB-1受体反向激动剂化合物和制药组合物,用于治疗肥胖症或与精神分裂症相关的认知障碍。